IE35693B1 - 1-phenoxy-2-hydroxy-3-hydroxyalkylaminopropanes and processes for their preparation - Google Patents

1-phenoxy-2-hydroxy-3-hydroxyalkylaminopropanes and processes for their preparation

Info

Publication number
IE35693B1
IE35693B1 IE1246/71A IE124671A IE35693B1 IE 35693 B1 IE35693 B1 IE 35693B1 IE 1246/71 A IE1246/71 A IE 1246/71A IE 124671 A IE124671 A IE 124671A IE 35693 B1 IE35693 B1 IE 35693B1
Authority
IE
Ireland
Prior art keywords
compound
formula
hydrogen
group
hydrolysing
Prior art date
Application number
IE1246/71A
Other versions
IE35693L (en
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of IE35693L publication Critical patent/IE35693L/en
Publication of IE35693B1 publication Critical patent/IE35693B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/64Oxygen atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1364280 1-phenoxy, 2-hydroxy, 3-hydroxyalkylamino-propanes BOEHRINGER INGELHEIM GmbH 4 Oct 1971 [5 Oct 1970] 46103/71 Heading C2C [Also in Division A5] Novel compounds of general Formula I and their esters and acid addition salts, where R 1 represents cyano, ethynyl, propargyl, allyl, amino, hydroxymethyl methoxy, hydroxycarbonyl methoxycarbonyl or allyloxy; R 2 represents a hydrogen, chlorine, methyl or cyano; or R 1 and R 2 together represent a 3,4- methylene-dioxy group; R 3 represents hydrogen and R 4 represents a straight or branched hydroxyalkyl group with 3 to 6 C atoms (with the proviso that R 4 is not 1,1-dimethyl-2- hydroxyethyl or 1,2 - dimethyl - 2 - hydroxyethyl when R 1 is 4-amino) are prepared by (1) reacting a compound of Formula II where Z represents the group or -CH.OH-CH 2 -Halogen with an amine NH 2 -R 4 , (2) hydrolysing or hydrogenolysing a compound of Formula IV where G is an acyl or tetrahydropyranyl group, (3) reacting a compound of Formula V with a hydroxyalkyl (with 3 to 6 C atoms)- halide, -tosylate or -mesylate or with a hydroxyaldehyde or hydroxyketone of 3 to 6 C atoms under conditions of reductive alkylation with hydrogen, (4) hydrolysing or hydrogenolysing a compound of Formula VI where Sch is preferably a benzyl carbobenzoxy or acyl group, (5) hydrolysing a compound of Formula VII preferably by using a strong alkali in an aqueous or aqueous/alcoholic medium, (6) hydrolysing or pyrolysing a compound of Formula VIII where R 5 and R 6 are either a hydrogen atom or an alkyl, aralkyl or aryl group, (7) chlorinating a compound Ar-OCH 2 -CHOH-CH 2 -NHR 4 , where Ar represents a phenyl group substituted by R<SP>1</SP> and R 3 preferably by using hydrogen peroxide and a hydrohalic acid, (8) reducing a compound II in which Z is CO-CH 2 -NHR 4 or CHOH-CO-NHR 4 , (9) reacting by known methods a compound X in which A is halogen, aldehyde, amide, oxime, haloalkyl nitro or alkoxy carbonyl to form a compound I in which R 1 is cyano, amino hydroxymethyl, or hydroxycarbonyl, or (10) reacting by known methods a compound X1 in which B is aldehyde or amino to form a compound I in which R 2 is other than hydrogen. Compounds I may be formed as their optical isomers. Acetates and propionates of compounds I may be formed by conventional procedures. Compounds I show #-adrenolytic activity and blood-pressure decreasing properties and form with a carrier or excipient a pharmaceutical composition which may be administered orally rectally or parenterally. The compositions may include coronary dilators, sympathicominetics cardiac glycosides or tranquillizers and in particular 2,6-bis-(diethanolamino-)-4,8-dipiperidino-pyrimido [5,4-d]-pyrimidine. [GB1364280A]
IE1246/71A 1970-10-05 1971-10-05 1-phenoxy-2-hydroxy-3-hydroxyalkylaminopropanes and processes for their preparation IE35693B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19702048838 DE2048838A1 (en) 1970-10-05 1970-10-05 New 1 phenoxy 2 hydroxy 3 hydroxyal kylaminopropane and process for their manufacture

Publications (2)

Publication Number Publication Date
IE35693L IE35693L (en) 1972-04-05
IE35693B1 true IE35693B1 (en) 1976-04-28

Family

ID=5784228

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1246/71A IE35693B1 (en) 1970-10-05 1971-10-05 1-phenoxy-2-hydroxy-3-hydroxyalkylaminopropanes and processes for their preparation

Country Status (26)

Country Link
JP (1) JPS5710097B1 (en)
AT (10) AT318564B (en)
AU (1) AU469119B2 (en)
BE (1) BE773472A (en)
BG (8) BG20100A3 (en)
CA (1) CA1008866A (en)
CH (11) CH583685A5 (en)
CS (2) CS172932B2 (en)
DE (1) DE2048838A1 (en)
DK (1) DK130958B (en)
ES (8) ES395671A1 (en)
FI (1) FI55491C (en)
FR (1) FR2110230B1 (en)
GB (1) GB1364280A (en)
HU (1) HU163226B (en)
IE (1) IE35693B1 (en)
IL (1) IL37830A (en)
NL (1) NL174249C (en)
NO (1) NO132835C (en)
PH (1) PH9959A (en)
PL (10) PL84225B1 (en)
RO (8) RO62357A (en)
SE (1) SE383631B (en)
SU (2) SU419024A3 (en)
YU (2) YU35576B (en)
ZA (1) ZA716643B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4055658A (en) * 1976-05-17 1977-10-25 Mead Johnson & Company Cyanomethylphenethanolamines
US4454154A (en) * 1981-06-23 1984-06-12 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
DE3248835A1 (en) * 1981-06-23 1983-06-30 American Hospital Supply Corp COMPOSITIONS FOR TREATING GLAUCOMA
US4652584A (en) * 1984-07-13 1987-03-24 Mcneilab, Inc. Acetylenic phenoxypropanol derivatives and pharmaceutical compositions for the treatment of hypertension
DE4422707A1 (en) * 1994-06-29 1996-01-04 Hoechst Ag Process for dyeing aminated cellulose / polyester blends with fiber-reactive disperse dyes
JP4934287B2 (en) * 2005-04-05 2012-05-16 花王株式会社 Whitening agent

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD45360A (en) *
CA945172A (en) * 1969-02-21 1974-04-09 Imperial Chemical Industries Limited Alkanolamine derivatives

Also Published As

Publication number Publication date
ES399868A1 (en) 1975-06-16
DK130958B (en) 1975-05-12
SU419024A3 (en) 1974-03-05
AT318569B (en) 1974-10-25
FI55491C (en) 1979-08-10
AT318567B (en) 1974-10-25
JPS5710097B1 (en) 1982-02-24
CH564515A5 (en) 1975-07-31
ES399870A1 (en) 1975-07-16
IE35693L (en) 1972-04-05
ES399872A1 (en) 1975-07-01
RO62313A (en) 1977-08-15
AT318566B (en) 1974-10-25
NO132835C (en) 1976-01-14
FR2110230A1 (en) 1972-06-02
FR2110230B1 (en) 1975-03-14
CH564516A5 (en) 1975-07-31
RO62355A (en) 1977-10-15
BG18857A3 (en) 1975-03-20
ES399869A1 (en) 1975-06-16
PH9959A (en) 1976-06-14
PL84224B1 (en) 1976-03-31
PL84212B1 (en) 1976-03-31
BG18858A3 (en) 1975-03-20
CH563342A5 (en) 1975-06-30
BG19134A3 (en) 1975-04-30
RO62267A (en) 1978-01-15
RO62359A (en) 1977-11-15
AU3418271A (en) 1973-04-12
CH587227A5 (en) 1977-04-29
NL174249C (en) 1984-05-16
SU677649A3 (en) 1979-07-30
BG19133A3 (en) 1975-04-30
PL82037B1 (en) 1975-10-31
RO61540A (en) 1977-02-15
DK130958C (en) 1975-10-13
AT318571B (en) 1974-10-25
PL84276B1 (en) 1976-03-31
BE773472A (en) 1972-04-04
ES395671A1 (en) 1974-10-16
PL84225B1 (en) 1976-03-31
PL84267B1 (en) 1976-03-31
ES399873A1 (en) 1975-07-01
BG20100A3 (en) 1975-10-30
FI55491B (en) 1979-04-30
IL37830A (en) 1975-03-13
CH584185A5 (en) 1977-01-31
HU163226B (en) 1973-07-28
AT318572B (en) 1974-10-25
BG20338A3 (en) 1975-11-05
SE383631B (en) 1976-03-22
RO62357A (en) 1977-10-15
AT318565B (en) 1974-10-25
CH564507A5 (en) 1975-07-31
DE2048838A1 (en) 1972-04-06
YU23679A (en) 1980-10-31
IL37830A0 (en) 1971-12-29
YU35577B (en) 1981-04-30
YU250571A (en) 1980-10-31
BG18859A3 (en) 1975-03-20
CH583685A5 (en) 1977-01-14
AT318561B (en) 1974-10-25
PL84227B1 (en) 1976-03-31
GB1364280A (en) 1974-08-21
AT318568B (en) 1974-10-25
CA1008866A (en) 1977-04-19
YU35576B (en) 1981-04-30
ES399871A1 (en) 1975-06-16
CH583686A5 (en) 1977-01-14
RO62358A (en) 1978-04-15
CH563341A5 (en) 1975-06-30
NL174249B (en) 1983-12-16
PL84226B1 (en) 1976-03-31
CS172950B2 (en) 1977-01-28
PL84223B1 (en) 1976-03-31
AU469119B2 (en) 1976-02-05
CS172932B2 (en) 1977-01-28
AT318570B (en) 1974-10-25
CH583687A5 (en) 1977-01-14
NL7113581A (en) 1972-04-07
NO132835B (en) 1975-10-06
ES399874A1 (en) 1975-07-01
RO62356A (en) 1977-08-15
PL84396B1 (en) 1976-03-31
AT318564B (en) 1974-10-25
BG19793A3 (en) 1975-10-10
CH587223A5 (en) 1977-04-29
ZA716643B (en) 1973-06-27

Similar Documents

Publication Publication Date Title
US4017608A (en) Therapeutic composition and method of therapeutically treating warm blooded animals therewith
SE409030B (en) PROCEDURE FOR THE PREPARATION OF CERTAIN STATED N-SUBSTITUTED BETA-AMINO-ALFA-BENZYLACRYLNITRILE DERIVATIVES
IE35693B1 (en) 1-phenoxy-2-hydroxy-3-hydroxyalkylaminopropanes and processes for their preparation
US4868303A (en) Bis-dioxopiperazine derivatives
CA2047770A1 (en) Pyrimidine derivatives
US3268582A (en) Phenylalkyl-carboxylic acid amides
US3939146A (en) Novel ethereal monosubstitutions of monosaccharide derivatives
IL39147A (en) Amino alcohols derived from ortho trans-hydroxycinnamic acids,their esters and their amides,preparation thereof and pharmaceutical compositions containing them
IE36071B1 (en) Furylmethyl-benzomorphane derivatives and pharmaceutical compositions containing them
IE36116L (en) N -(furylmethyl)morphinanes
USRE30379E (en) Ethereal monosubstitutions of monosaccharide derivatives
US4232023A (en) Novel soluble derivatives of 2,4-diamino pyrimidine
EP0049565A3 (en) Derivatives of substituted n-alkylimidazoles, their preparation and pharmaceutical compositions containing them
GB1031425A (en) New aralkylamines and their preparation
Raiziss et al. 2-Sulfanilyl-aminothiazoline
SE7415015L (en) METHODS OF PRODUCING NEW 2-PHENYLHYDRAZINO-THIAZOLINES OR -TIAZINES
US3037977A (en) Production of compounds of the pyrimidine series
ES2029830T3 (en) A PROCEDURE FOR PREPARING A DERIVATIVE OF 6-CETOPROSTAGLANDINA E1.
GB1295206A (en)
DK455285D0 (en) 2-pyridin-thiol derivatives
US2543267A (en) Hydroxyethyl-acylamidobiphenylyl ketones
US3472871A (en) 1 - methyl - 3 - hydroxy - 6 - oxo - 5 - ((amido) alkanoyl - hydrozo) -2,3,5,6-tetrahydroindoles
US3415866A (en) alpha-alkylidene-3,4-disubstituted-phenylacetonitriles
US2753347A (en) Dihydroqrotic acid
US5393889A (en) Water soluble bis-dioxopiperazine derivatives